Health experts have warned against underestimating the risks of "indolent tumors" as China observes its 30th "National ...

The turning point came when Suki received a diagnosis that shed light on her mysterious symptoms: indolent systemic mastocytosis (ISM). ISM is a rare disease, estimated to occur in approximately 1 ...

Jill Zinsmeyer came to Austin for love, but Austin didn't love her. Living in Napa Valley, Calif., before the move, Zinsmeyer ...

Harvard’s endowment is currently $50.7 billion. That means that the first year, the state would extract about $1.25 billion ...

Blueprint boosts Ayvakit peak sales estimate to $2B as key rare disease expansion accelerates Meanwhile, Blueprint these days ...

Among more than 1,300 patients diagnosed with HCC, the median survival reached 37 months for those with screening-detected ...

Blueprint Medicines Corporation BPMC reported first-quarter 2024 adjusted loss of $1.32 per share, narrower than the Zacks ...

Purpose. The pharmacology, efficacy, safety, and dosage and administration of bendamustine and its use in indolent non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) are reviewed.

Blueprint Medicines Corporation (Nasdaq: BPMC) today reported financial results, provided a business update for the first ...

This is an open-label trial in which 100 patients with rituximab-refractory indolent B-cell NHL were treated bendamustine 120 mg/m 2 on days 1 and 2 of every 21-day cycle for six to eight cycles.

HAMPTON ROADS, Va. — Hematologist and Oncologist Dr. Pankit Vachhani and Suki Tipp, a woman living with Indolent Systemic Mastocytosis, join Coast Live to discuss the debilitating disease ...

Health experts have warned against underestimating the risks of "indolent tumors" as China observes its 30th "National Anti-Cancer Week" from April 15-21. Certain cancers, which exhibit relatively ...